Stock data
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA) reported net income of -US$106.19M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$112.79M | -US$106.19M | — |
| 2024 | — | — | -US$96.12M | -US$86.92M | — |
| 2023 | — | — | -US$84.99M | -US$76.41M | — |
| 2022 | — | — | -US$60.30M | -US$58.76M | — |
| 2021 | — | — | -US$35.25M | -US$35.25M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$45.64M | — |
| 2026-03-31 | — | -US$33.69M | — |
| 2025-12-31 | — | -US$25.56M | — |
| 2025-09-30 | — | -US$26.13M | — |
| 2025-06-30 | — | -US$27.02M | — |
| 2025-03-31 | — | -US$27.48M | — |
| 2024-12-31 | — | -US$25.83M | — |
| 2024-09-30 | — | -US$21.04M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.